Testosterone Treatment for Erectile Dysfunction and Multiple Sclerosis
Part of paid clinical trials in New Orleans, Louisiana.
- Sponsor
- Tulane University
- Study ID
- NCT04601233
- Phase
- PHASE4
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Erectile Dysfunction
- Multiple Sclerosis
- Testosterone Deficiency
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- XYOSTED 75 milligram (mg) in 0.5 ML Auto-Injector — DRUGSelf injection testosterone treatment
Study Details
The purpose of the study is to determine the effects of testosterone treatment on erectile function, fatigue, depression, cognitive function, quality of life, urinary incontinence, pain, and damage to neurons in male Multiple Sclerosis patients with low testosterone, using questionnaires, blood samples and a rectal exam in volunteers 55 years and older.
Key Dates
- Start date
- Jun 30, 2026
- Status verified
- Aug 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Treatment open label armOpen-label feasibility study to determine the effects of testosterone (Xyosted 75mg subcutaneous once per week for 3 months) on erectile function in male Multiple Sclerosis patients with low testosterone.
Primary Outcome Measure
Determine the change in self-reported erectile function from baseline to 12-weeks after 12 weeks of treatment with XYOSTED in males with Multiple Sclerosis with low testosterone using Androgen Deficiency in the Aging Male (ADAM score). [ Time Frame: Change from baseline to 12 weeks ]
Central Contacts
- Michael Soliman, MD504-756-4603
- Jesus Lovera, MD504-568-4080
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| LSU Health Multispecilaity Clinics | New Orleans | Louisiana | 70112 | Michael Soliman, MD |
Find similar trials in New Orleans, LA
Related Studies
- IT Matters: The Erectile Restoration RegistryEnrolling By Invitation · Boston Scientific Corporation · Los Angeles, California
- A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)PHASE1 · Recruiting · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · Birmingham, Alabama
- Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)Recruiting · National Institute of Neurological Disorders and Stroke (NINDS) · Bethesda, Maryland
- Serum Auto-Antibodies in Neurological DiseasesEnrolling By Invitation · University of California, Davis · Sacramento, California